Stanford University
Showing 12,101-12,200 of 13,057 Results
-
Yiyu Wang
Postdoctoral Scholar, Anesthesiology, Perioperative and Pain Medicine
BioDr. Yiyu Wang is a T32 postdoctoral researcher at the Department of Anesthesiology, Stanford School of Medicine. Her research combines computational models and neuroimaging techniques to characterize the neural architecture underlying complex human experiences in emotion and pain. Her current work focuses on leveraging deep learning, foundation models, and explainable AI to improve neuroimaging-based markers as well as multi-modal markers of chronic pain.
-
Yunyun Wang
Postdoctoral Scholar, Cardiovascular Medicine
BioYunyun is a postdoctoral scholar in Cardiovascular Medicine at Stanford. She received her PhD in Genetics from Zhejiang University in China (2025), where she studied the metabolic-epigenetic mechanisms of cardiovascular disease such as atherosclerosis and angiogenesis. In 2026, she joined the Quertermous Lab, where her research focuses on uncovering the mechanisms underlying atherosclerosis using Perturb-seq technology.
-
Dr. Zhiyong Wang
Visiting Scholar, Genetics
BioDr. Wang is the acting director of the Department of Plant Biology, Carnegie Institution for Science, and a professor by courtesy of the Department of Biology, Stanford University. He is currently an associate editor of Molecular Cellular Proteomics, and editorial board member of Molecular Plant. He is a Fellow of the American Association for the Advancement of Science (AAAS) and recipient of the Humboldt Research Prize.
Dr. Wang obtained his Ph.D. in 1998 from UCLA, where he cloned the plant circadian clock gene CCA1. He did his postdoctoral research at the Salk Institute, where he studied the brassinosteroid signaling mechanism mediated by the BRI1 receptor kinase. Since joining Carnegie in 2001, his research has illustrated the receptor kinase signaling pathway that links the BRI1 receptor kinase to the BZR1 transcription factor and brassinosteroid-responsive genes in the Arabidopsis genome. He further demonstrated how the steroid signaling pathway integrates at the molecular level with other hormonal pathways, light signaling pathways, nutrient-sensing pathways, immunity pathways, and the circadian clock, to coordinately regulate plant growth and development. His lab uses combinations of genomic and proteomic approaches to understand how cellular signals are transduced and integrated through posttranslational modifications (e.g. phosphorylation and O-Glycosylation) and protein-protein interactions. His studies are elucidating the molecular mechanisms that control plant growth and mediate responses to environmental changes. -
Ziwei Wang
Postdoctoral Scholar, Radiation Therapy
Current Research and Scholarly InterestsMy current work focuses on establishing preclinical platforms to rapidly validate the functional impact of genetic alterations in tumors using both cell and genetically engineered mouse models. We hope this system can accelerate the discovery and translation of novel cancer therapies to patients.
-
Zongyi Wang
Postdoctoral Scholar, Psychiatry
Current Research and Scholarly InterestsSleep disruptions in neurodegenerative disorders
-
Irene Wapnir, MD
Professor of Surgery (General Surgery)
Current Research and Scholarly InterestsClinical trials in operative procedures such as Nipple-sparing mastectomy, arm lymphatic mapping, skin perfusion and Treatments for Breast Cancer, especially local recurrence. Dr. Wapnir is institutional Principal Investigator and Chair for National Surgical Adjuvant Breast and Bowel Project (NSABP) clinical trials. Laboratory and translational research includes exploring the activity of breast iodide transporter in breast cancer brain metastasis.
-
(Alex) Alexandra Ward
Clinical Research Coordinator Associate, Pediatrics - Endocrinology
Bio(Alex) Alexandra Ward is a Clinical Research Coordinator in the Department of Pediatric Endocrinology at Stanford University School of Medicine. She works on a broad portfolio of clinical research studies focused on improving health outcomes for children and adolescents through patient-centered, technology-enabled, and equity-focused approaches. In her role, she coordinates industry-sponsored and investigator-initiated studies, oversees participant recruitment and study operations, manages regulatory compliance, and contributes to qualitative and quantitative data analysis, scientific writing, and dissemination of research findings.
Alexandra earned her Bachelor of Arts in Sociology with a focus on Pre-Medical Studies from the University of California, Berkeley. Her academic and research interests center on epidemiology, population health, and the social and structural factors that influence health across the lifespan. She is particularly interested in health equity, social determinants of health, implementation science, digital health technologies, aging, and the use of artificial intelligence to improve healthcare delivery and reduce disparities among underserved populations.
Her research experience spans pediatric endocrinology, chronic disease management, epidemiology, mixed-methods research, patient-reported outcomes, and community-engaged research. She has contributed to multiple peer-reviewed publications and scientific presentations and has collaborated on studies examining diabetes technology, healthcare access, quality of life, and interventions designed to improve health outcomes for diverse patient populations.
Alexandra plans to pursue a PhD in Epidemiology, where she hopes to develop innovative, data-driven approaches to address complex public health challenges and advance equitable healthcare through interdisciplinary research. -
Katherine T. Ward, MD
Clinical Professor, Medicine - Primary Care and Population Health
BioDr. Ward is the Chief of the Geriatrics Section in the Department of Medicine, Division of Primary Care and Population Health at Stanford University School of Medicine, and a Clinical Professor of Medicine. In this leadership role, she supervises program leaders across outpatient, inpatient, and skilled nursing facility settings, bringing them together to provide longitudinal, coordinated care to older adults across the healthcare continuum.
Dr. Ward is a fellowship-trained geriatrician with Stanford in Palo Alto, California, and is board certified in geriatric medicine, hospice and palliative medicine, and internal medicine. Her clinical practice spans all care settings—outpatient clinics, hospitals, and skilled nursing facilities—with a focus on managing the critical transitions between them. She specializes in comprehensive care for older adults, including dementia care, palliative care, geriatric assessment, and best practices in nursing home care. Dr. Ward draws on her extensive experience to teach and implement evidence based models that support care for older adults. Dr. Ward's research interests include early detection of dementia in vulnerable populations, dementia care support programs, and geriatric assessment in diverse populations.
She has published her research in peer-reviewed journals including the Journal of the American Geriatrics Society; The American Journal of Geriatric Pharmacotherapy; The Journal of Nutrition, Health & Aging; and the Journal of Palliative Medicine. She has served as an ad hoc reviewer for several journals, including Geriatrics, and has presented posters at annual meetings of the American Geriatrics Society and the Society of General Internal Medicine.
Dr. Ward is a member of the American College of Physicians and the American Geriatrics Society. -
Victoria Ward
Clinical Professor, Pediatrics
Current Research and Scholarly InterestsGlobal child health, Health AI in LMICs, preterm birth, human trafficking
https://digitalmedic.stanford.edu/
https://htdatalab.stanford.edu/ -
Chisondi S. Warioba, PhD
Postdoctoral Scholar, Anesthesiology, Perioperative and Pain Medicine
BioChisondi S. Warioba, PhD, is a Postdoctoral Scholar in the Division of Pain Medicine at the Stanford University School of Medicine, working in the Department of Anesthesiology, Perioperative and Pain Medicine with Dr. Sean Mackey and Dr. Kenneth Weber. His research develops machine learning and deep learning approaches for high-dimensional medical data, with an emphasis on cross-species translational neuroscience, resting-state fMRI, and multimodal MRI analysis (NODDI, DKI, and advanced diffusion techniques) to identify brain biomarkers of chronic pain.
He earned his PhD in Medical Physics from the University of Chicago, where his dissertation focused on cross-species mapping of functional connectivity alterations and therapeutic responses in hyperacute ischemic stroke. He completed a triple-major bachelor's degree in Chemistry, Physics, and Biology at Westmont College.
Dr. Warioba is a National Science Foundation Graduate Research Fellow and was awarded an Academic Visitor position at the University of Oxford's Department of Clinical Neurosciences. He received the Carl B. Allendoerfer Award from the Mathematical Association of America for expository excellence. He is committed to mentorship and community engagement, including STEM outreach for underrepresented students and neuroscience public education. -
Roger Warnke
Ronald F. Dorfman, M.B.B.ch., FRCPath, Professor in Hematopathology, Emeritus
Current Research and Scholarly InterestsAs an Emeritus Professor, I no longer have a research laboratory and am now fully retired.
-
Jenli Dawn Waters, MD
Clinical Assistant Professor, Neurosurgery
BioDr. Waters is a board-certified, fellowship-trained neurosurgeon with the Neurosurgery Program at Stanford Health Care. She is also a clinical assistant professor of neurosurgery in the Department of Neurosurgery at Stanford University School of Medicine.
Dr. Waters specializes in treating a wide range of spinal conditions. These treatments include surgery to relieve numbness or pain related to pressure on the spinal cord and procedures to repair or stabilize the spinal column (spine fusion). Her areas of expertise also include diagnosis and treatment of traumatic brain injury and brain and spinal cancers.
Dr. Waters’ research experience includes helping to develop effective strategies for diagnosing
and treating patients with different neurological cancers, including glioblastomas. As a subspecialty medical expert for spine and neurosurgery, she successfully advocated for insurance coverage of state-of-the-art, minimally invasive approaches to treating epilepsy and brain tumors.
Dr. Waters has published her work in peer-reviewed journals, including the Journal of Neurosurgery and the Journal of Neuro-Oncology. She has also authored and co-authored chapters in numerous books describing neurosurgical techniques and the diagnosis and treatment of various neurological conditions, including brain and spinal cord tumors.
Dr. Waters is a member of the Congress of Neurological Surgeons. -
Ronald D. Watkins
Senior Research Engineer, Rad/Radiological Sciences Laboratory
Current Role at StanfordMy current position is Senior Research Associate in the Radiological Sciences Laboratory and the Molecular Imaging Laboratory in the Department of Radiology at Stanford School of Medicine. I provide hardware, systems, and general technical support for a large group of Faculty members and many students and post docs in the development of advanced medical imaging, metabolic imaging and image-guided interventions. My training background is primarily in RF and electrical engineering. I have spent more than 25 years in the commercial diagnostic imaging industry. Most of the projects I am currently working on involve instrumentation for metabolic imaging using magnetic deuterium imaging. I am also involved in the development of Hybrid systems that combine Positron Emission Tomography and Magnetic Resonance imaging. Other projects I am involved in use focused ultrasound for neuro-stimulation or drug delivery via blood brain barrier. I also provide RF coil design and support for small animal imaging and various research studies. I have ongoing collaborations with many other medical research institutes and Universities around the world. I currently have 45 issued US patents, and 100 pear reviewed publications.
-
Erin Watson, PsyD, ABPP
Clinical Associate Professor, Medicine - Gastroenterology & Hepatology
BioErin Watson, PsyD, ABPP, is a board-certified clinical health psychologist and Clinical Associate Professor in the Division of Gastroenterology & Hepatology at Stanford University School of Medicine. She specializes in helping people understand and manage the psychological, behavioral, and lifestyle factors that can affect their physical health. Her clinical interests include coping with chronic illness, managing stress and health-related anxiety, making sustainable health behavior changes, and using evidence-based mind-body and behavioral approaches to improve symptoms, functioning, and quality of life.
Dr. Watson has specialized in health psychology and behavioral medicine throughout her education, training, and career. She completed her doctoral training with an emphasis in Primary Care Psychology and Behavioral Medicine, followed by advanced training in health psychology and integrated medical care and a postdoctoral fellowship focused on infectious and liver diseases. Before joining Stanford, she spent more than a decade at the San Francisco VA and UCSF providing behavioral health care within medical settings, including primary care, chronic pain, liver and infectious disease, bariatric medicine, and outpatient health psychology.
At Stanford, Dr. Watson is part of GI & Liver Behavioral Medicine, where she works with adults living with digestive and liver conditions. Her work in psychogastroenterology addresses the important connections between the brain, behavior, and digestive system. She also has a particular interest in advancing psycho-hepatology, which brings health psychology and behavioral medicine into liver care. Her goal is to help patients develop practical skills for coping with illness, managing symptoms and stress, changing health behaviors, and living well alongside chronic medical conditions.
Dr. Watson is a dedicated clinician-educator with more than a decade of experience teaching and supervising psychology trainees and educating healthcare professionals across disciplines. Her current academic work includes research examining behavioral approaches to chronic pain and opioid use through a National Institutes of Health-funded study, as well as a recently funded Patient-Centered Outcomes Research Institute (PCORI) study evaluating behavioral interventions for people living with rare liver diseases. Across her clinical care, research, teaching, and program development, she works to advance the integration of psychological and behavioral science into medical care and improve the health and quality of life of people living with chronic disease. -
Kathleen Watson
Clinical Assistant Professor, Psychiatry and Behavioral Sciences
BioKathleen Watson, Ph.D., currently serves as an instructor at Stanford University School of Medicine, specializing in Epidemiology and Clinical Research. She co-founded Microclinic International in 2007, where she served as Chief Operating Officer until 2012, focusing on socially-based health interventions for underserved communities.
Dr. Watson's research encompasses various aspects of mental health and metabolism. She investigates the connection between insulin resistance and depression, using computational psychiatry to uncover insights into the interplay of metabolic factors in mental well-being. Additionally, her exploration of cognitive aging examines how metabolic alterations might impact cognitive decline and related disorders. Furthermore, her research in proteomics aims to identify potential biomarkers for severe major depressive disorder. Dr. Watson has recently become a part of the Stanford Autism Center for Excellence Data Core, where she works under the guidance of Dr. Booil Jo. -
Robert Waymouth
Robert Eckles Swain Professor of Chemistry and Professor, by courtesy, of Chemical Engineering
BioRobert Eckles Swain Professor in Chemistry Robert Waymouth investigates new catalytic strategies to create useful new molecules, including bioactive polymers, synthetic fuels, and sustainable plastics. In one such breakthrough, Professor Waymouth and Professor Wender developed a new class of gene delivery agents.
Born in 1960 in Warner Robins, Georgia, Robert Waymouth studied chemistry and mathematics at Washington and Lee University in Lexington, Virginia (B.S. and B.A., respectively, both summa cum laude, 1982). He developed an interest in synthetic and mechanistic organometallic chemistry during his doctoral studies in chemistry at the California Institute of Technology under Professor R.H. Grubbs (Ph.D., 1987). His postdoctoral research with Professor Piero Pino at the Institut fur Polymere, ETH Zurich, Switzerland, focused on catalytic hydrogenation with chiral metallocene catalysts. He joined the Stanford University faculty as assistant professor in 1988, becoming full professor in 1997 and in 2000 the Robert Eckles Swain Professor of Chemistry.
Today, the Waymouth Group applies mechanistic principles to develop new concepts in catalysis, with particular focus on the development of organometallic and organic catalysts for the synthesis of complex macromolecular architectures. In organometallic catalysis, the group devised a highly selective alcohol oxidation catalyst that selectively oxidizes unprotected polyols and carbohydrates to alpha-hyroxyketones. In collaboration with Dr. James Hedrick of IBM, we have developed a platform of highly active organic catalysts and continuous flow reactors that provide access to polymer architectures that are difficult to access by conventional approaches.
The Waymouth group has devised selective organocatalytic strategies for the synthesis of functional degradable polymers and oligomers that function as "molecular transporters" to deliver genes, drugs and probes into cells and live animals. These advances led to the joint discovery with the Wender group of a general, safe, and remarkably effective concept for RNA delivery based on a new class of synthetic cationic materials, Charge-Altering Releasable Transporters (CARTs). This technology has been shown to be effective for mRNA based cancer vaccines. -
Annika M. Weber
Postdoctoral Scholar, Gastroenterology
BioAnnika is a postdoctoral scholar in the Spencer Lab studying how gut microbes metabolize prebiotic fibers to produce bioactive metabolites linked to lowering disease risk. She holds an MS in Human Nutrition from the University of Sheffield and a PhD in Food Science and Human Nutrition from Colorado State University. Her work integrates multi-omic approaches to map diet-microbe-metabolite relationships. Annika aims to translate these mechanistic insights into microbiome-informed dietary strategies for reducing chronic diseases.
-
Kenneth Weber, DC, PhD
Assistant Professor (Research) of Anesthesiology, Perioperative and Pain Medicine (Adult Pain) and, by courtesy, of Neurosurgery (Adult Neurosurgery) and of Radiology (Neuroimaging and Neurointervention)
BioDr. Weber directs the Neuromuscular Insight Lab. Dr. Weber's research seeks to develop quantitative markers of sensory and motor function, including pain, using machine-learning and advanced brain, spinal cord, and musculoskeletal magnetic resonance imaging. Dr. Weber aims to use these techniques to better understand the neuropathology of neurological and musculoskeletal conditions and discover more effective treatments and preventative strategies.
-
Leila Wehbe
Associate Professor of Biomedical Data Science and of Neurology and Neurological Sciences (Adult Neurology)
BioLeila Wehbe is an Associate Professor of Biomedical Data Science and of Neurology and Neurological Sciences at Stanford University. Her research focuses on understanding how the human brain represents and processes information during naturalistic cognition. She brings together neuroscience and machine learning, using tools like fMRI and MEG to build computational models of brain activity during complex cognitive processes such as language comprehension and high-level visual processing. Her work examines what brains and artificial systems can reveal about one another.
-
Mike Tzuhen Wei
Clinical Assistant Professor, Medicine - Gastroenterology & Hepatology
BioDr. Wei was born and raised in Taipei, Taiwan. He went to Stanford for his undergraduate studies in Biology and earned his medical degree at Weill Cornell Medical College. Unable to stay far from the Bay Area, he returned to Stanford where he completed his residency in internal medicine and subsequently his fellowship in gastroenterology. Dr. Wei has specific interests in colorectal cancer and Barrett’s esophagus surveillance as well as reflux diagnosis and management. He has an interest in endoscopic resection of large polyps and had received training under Dr. Shai Friedland, a world expert in this field. Dr. Wei work focuses on evaluating new tools, technologies and techniques in gastrointestinal cancer surveillance and management. He has been involved in running several trials in endoscopic management of polyps and evaluating artificial intelligence applications in gastroenterology. His work has been published in American Journal of Gastroenterology, Gastrointestinal Endoscopy, Clinical Endoscopy, VideoGIE, and Digestive Diseases and Sciences. He was formerly an Associate Editor for the ACG Case Report Journal (2020-2022) and was on the Board of the Northern California Society of Clinical Gastroenterology. When not in clinic or in endoscopy, Dr. Wei enjoys spending time with his family. He and his family enjoy traveling and exploring new restaurants.
-
Ruolun Wei
Postdoctoral Scholar, Neurosurgery
BioRuolun Wei, MD, PhD, is a postdoctoral scholar in the Department of Neurosurgery at Stanford University. Dr. Wei’s work centers on neuro-oncology, with particular emphasis on brain tumor recurrence, treatment resistance, and tumor metabolism. He is also a board-certified neurosurgeon, currently focusing on full-time research. His research aims to bridge the gap between clinical practice and laboratory investigation, conducting translational research that moves from bedside to bench and back to bedside to improve therapeutic outcomes for patients with malignant brain tumors.
-
Tan Wei Ting
Affiliate, Neurosurgery
BioWei Ting graduated from University Malaya under the Department of Biomedical Engineering (Bachelor & Master's).Apart from multidisciplinary (tissue engineering, medical imaging, computational biology) research experience, she has worked in startups, industry, clinics, and medical centres with exposure to rehabilitation robotics, TCM in fertility, and clinical trials.
Her past undergraduate research experience includes
1. Dr Belinda Murphy’s Tissue Engineering Lab to assist in cell culturing and cytotoxicity testing
2. Asian Cardiac Laboratory under Dr Lim Einly for medical imaging-based investigation of flow energetics and vortex parameters in heart attack patients
For master's research, funded under Newton Advanced Fellowship in collaboration with Imperial College London’s Prof Xu group and UTM's Dr Mohd Jamil’s group.
1. Research focus: investigating the risk factor of distal stent induced new entry in aortic dissection patients using both simplified and patient-specific models.
2. Presented in local and international conference, published peer review studies and has reviewed paper relevant to the project.
With curiosity for knowledge, arts, philosophy, and the sciences, she often diving into new fields, moves across disciplines, and combines several areas of knowledge. She gained both lab-based and computational skills, for example: bioinformatics, pharmacokinetic modelling, cell staining, confocal microscopy, FRET cell transfection, live cell imaging, image processing, high-performance computing, quantum algorithms, etc.
At MSU, she is part of the Tau Beta Pi National Honor Society and Cloud Computing Foundations (CCF) Program. For the cloud program, her interest is in applying a hybrid quantum-classical computational framework to small-molecule drug development. She is currently a PhD student in Biomedical Engineering from Michigan State University, performing computational analysis and exploring quantum algorithms for biomedical applications in cell and gene regulatory networks.
Wei Ting has been active in learning more about different facets of medicine and often engages with researchers and physicians. She has gained familiarity with neurological disease (e.g. autism, Parkinson's, and Alzheimer's) from different perspectives (e.g., rehabilitation robotics, brain simulation, and psychiatry). She is invited to join the Neurobehavior and Neuroscience Methods Workshop (SPrINT/Stanford) in 2026. -
Katja Gabriele Weinacht, MD, PhD
Assistant Professor of Pediatrics (Stem Cell Transplantation and Regenerative Medicine)
Current Research and Scholarly InterestsPediatric Hematopoietic Stem Cell Transplantation
DiGeorge Syndrome
Genetic Immune Diseases
Immune Dysregulation -
Ann Weinacker
Professor of Medicine (Pulmonary and Critical Care)
On Leave from 2026-09-08 To 2027-09-07Current Research and Scholarly InterestsDr. Weinacker's research interests center around ICU outcomes. Her specific interests include primary graft dysfunction in lung transplant recipients.
-
Alexis Thomas Weiner
Basic Life Research Scientist, Pathology Sponsored Projects
Current Research and Scholarly InterestsThe planar cell polarity (PCP) signaling pathway polarizes animal cells along an axis parallel to the tissue plane, and in so doing generates long-range organization that can span entire tissues. Although its core proteins and much about their interactions are known, how PCP signaling occurs at a mechanistic level remains fundamentally mysterious. In my current project I will employ novel genetic methods to dissect the logic underlying how cellular asymmetry arises at a molecular level.
-
Eva Weinlander
Clinical Professor, Medicine - Primary Care and Population Health
Current Research and Scholarly InterestsWomen's Health
Mind Body Medicine
Chronic Disease Management -
Dana Weintraub
Member, Maternal & Child Health Research Institute (MCHRI)
Current Research and Scholarly InterestsResearch interests include: 1) Childhood obesity, community-based interventions to increase physical activity 2) Impact of medical-legal collaboration on child and family health.
-
Thomas G Weiser, MD, MPH
BioDr. Thomas Weiser is a general, emergency, and trauma surgeon, and surgical intensivist. He treats and cares for injured patients and those with acute surgical emergencies as well as manages critically ill surgical patients in the Intensive Care Unit.
His research has focused on evaluating the role surgical care plays in the delivery of health services in resource poor settings, in particular low and middle income countries. He is interested in barriers to access and provision of surgical care, the quality of surgical services, and outcomes research as well as the science of implementation, how improvements can be made, and how to strengthen compliance with best practices and change behaviors for the better. He also has an interest in domestic policy as it relates to trauma outcomes, trauma systems, insurance coverage and costs of care, and firearm violence.
Dr. Weiser's efforts have led to improvements in the safety and reliability of surgical service, the quality of surgical care delivered globally, and improvements team dynamics, function, and communication. He works closely with Lifebox, a nonprofit focused on improving surgical and anesthetic safety worldwide, where he was previously the Consulting Medical Officer. Lifebox delivers programs throughout the world in combination with local partners and includes the procurement and distribution of low cost devices to improve the safety of care (including pulse oximeters for the routine monitoring of patients undergoing anesthesia and surgical headlights to safeguard care during power outage) and Clean Cut, a surgical infection prevention and control program that has reduced complications by up to 50%. This work safeguards millions of surgical patients every year.
From 2006-2009, he was part of the World Health Organization’s Safe Surgery Saves Lives program where he quantified the global volume of surgery and created, implemented, evaluated, and promoted the WHO Surgical Safety Checklist. He was part of the Lancet Commission on Global Surgery, the World Bank Disease Control Priorities Program, and a Gates Grand Challenge awardee.
From 2022-2026 he was the Program Director of Surgery: Assess/Validate/Expand (SAVE) at Wellcome Leap. His current research efforts aim to accelerate computer vision models for quantifying surgical performance and identifying mechanisms to predict patient recovery trajectories following surgery. -
Eric A Weiss, MD, FACEP
Professor of Emergency Medicine at the Stanford University Medical Center, Emeritus
Current Research and Scholarly InterestsMy focus of research is wilderness medicine, including hypothermia, heat illness, altitude illness, improvised medical care in austere environments and wound care. I also have a strong interest in Disaster Medicine, Travel Medicine and International Health, and Pandemics.
-
Eric L. Weiss, MD, DTM&H
Current Research and Scholarly InterestsIgnorance of Hepatitis A Among Travelers (writing up data).Travelers Neglecting to Seek Pre Travel Medicine Advice (writing up data).Fluoroquinolones in the Treatment of Complicated Urinary Tract Infections (new ED study)
-
Irving Weissman
Virginia & D.K. Ludwig Professor of Clinical Investigation in Cancer Research, Professor of Pathology, and of Developmental Biology
Current Research and Scholarly InterestsStem cell and cancer stem cell biology; development of T and B lymphocytes; cell-surface receptors for oncornaviruses in leukemia. Hematopoietic stem cells; Lymphocyte homing, lymphoma invasiveness and metastasis; order of events from hematopoietic stem cells [HSC] to AML leukemia stem cells and blood diseases, and parallels in other tissues; discovery of tumor and pathogenic cell 'don't eat me' and 'eat me' signals, and translation into therapeutics.
-
Chad S. Weldy, M.D., Ph.D.
Assistant Professor of Medicine (Cardiovascular Medicine)
Current Research and Scholarly InterestsThe Weldy Lab studies how human genetic variation drives vascular dysfunction, inflammation, and cardiovascular disease. We integrate human genetics, epigenetics, single-cell genomics, RNA biology, and experimental models to define causal mechanisms and identify new therapeutic opportunities.
Led by Chad S. Weldy, MD, PhD, the lab focuses on questions at the intersection of cardiovascular genetics, vascular biology, and RNA-mediated regulation, with particular interest in smooth muscle cell phenotypic modulation, innate immune signaling, and mechanisms of disease susceptibility governed by epigenetic memory.
Our work is grounded in the idea that genetic discovery can do more than identify risk. It can reveal the biology that matters most and point toward more precise strategies for prevention and treatment.
https://weldylab.org/ -
Andy Wen
Clinical Professor, Pediatrics - Critical Care
BioDr. Andy Y. Wen joined the Division of Pediatric Critical Care Medicine at Stanford University School of Medicine in 2019. He received his B.A. degree in Molecular Biology & Biochemistry at Rutgers University, and his medical degree from Rutgers Robert Wood Johnson Medical School. He completed a Pediatrics Residency Training Program at the State University of New York Downstate Medical Center and a Pediatric Critical Care Medicine Fellowship Training Program at the University of California Los Angeles.
After briefly working for Kaiser Permanente Southern California Permanente Medical Group, Dr. Wen joined the Division of Pediatric Critical Care at NYU School of Medicine. He assumed the role of Bellevue Hospital PICU medical director and helped to expand Bellevue's Pediatric Trauma Program and Pediatric Critical Care Transport Services for the New York City (NYC) public hospital system, NYC Health & Hospitals. During the 2014 to 2016 Ebola outbreak in West Africa, Dr. Wen was a member of the Special Pathogens Program at Bellevue Hospital, which was one of only four institutions in the US to treat a patient with Ebola and helped established the National Ebola Training and Education Center (NETEC).
While at UCLA, Dr. Wen received a T32 Training Grant to perform research investigating the role of transcription factor CREB in innate immune function using a murine model for AML. At NYU, his research projects included analyzing transfusion practices in the PICU, quality improvement projects targeting patients at high risk for unplanned extubation, and exploring the utility of NIRS as an early predictor of seizure activity. Dr. Wen is a member of Pediatric Acute Lung Injury & Sepsis Investigators (PALISI) and has been involved in multi-center studies looking at critical care patients with Bronchiolitis and COVID-19. Dr. Wen is the USA Editor for Journal of Pediatric Intensive Care and has reviewed abstracts for PAS, SCCM, and AMIA. His educational efforts have included teaching Pediatric Fundamental Critical Care Support (PFCCS) courses, helping develop a Pediatric Residency Simulation course curriculum, and helping develop a Point-of-Care Ultrasound course for critical care advanced practice providers.
At Stanford University School of Medicine, Dr. Wen is in charge of Regional Pediatric Critical Care Outreach with a goal to promote medical education and expand the Stanford Children’s Health network to improve access for sick children in need of high quality care. Dr. Wen provides clinical services at both John Muir Medical Center and Lucile Packard Children’s Hospital. -
Gerald Wen
IT Manager, Anesthesiology, Perioperative and Pain Medicine
Current Role at StanfordIT Manager
Tuesday/Thursday @ Redwood City Campus, Discovery Hall -
Paul Wender
Francis W. Bergstrom Professor and Professor, by courtesy, of Chemical and Systems Biology
Current Research and Scholarly InterestsMolecular imaging, therapeutics, drug delivery, drug mode of action, synthesis
-
Kirsti Weng Elder MD/MPH
Clinical Associate Professor, Medicine - Primary Care and Population Health
BioDr. Weng was the Section Chief of General Primary Care from 2020-2023. Dr..Weng has served in roles as Medical Director, and leader of care programs as well as improvement projects. She enjoys leading doctors and strives to inspire those around her to practice patient-centered care as well as physician self-care. She is a leader in organizational change and physician management. As a leader in primary care re-design, she is passionate about balancing the needs of the patient, provider and health care institution. She is an advocate of Mindfulness Self-compassion. Dr Weng is currently semi-retired. She works in the Express Care Clinic as a provider and does individual life and executive coaching.
Kirsti Weng Elder has over 35 years of experience caring for patients in primary care, urgent care and in the hospital. She is a teacher of students and residents. She practices with an emphasis on musculoskeletal care as she feels fitness is a foundation for wellness.
Kirsti supports community health and care for the underserved. Outside of work she enjoys biking, reading and spending time with her 8 children. She is on the board of the Valley Health Foundation. -
Wen-Kai Weng, MD, PhD
Professor of Medicine (Blood and Marrow Transplantation and Cellular Therapy) and, by courtesy, of Dermatology
Current Research and Scholarly InterestsMy research interest is on immunotherapy (including allogeneic transplant) of cancer. I have studies the mechanism of monoclonal antibody therapy in lymphoma patients and am currently working on designing new strategy to enhance the clinical efficacy of antibody therapy by infusing expanded NK cells. I am also interested in using tumor vaccine along with hematopoietic cell transplant.
-
Yingjie Weng
Assistant Director, Learning Health Systems Program, Med/Quantitative Sciences Unit
Current Role at StanfordResponsibilities - Assistant Director, Learning Health Systems Program (LHS)
Program Development & Resource Management
•Establish and update LHS program resources, including standard operating procedures, statistical analysis plan templates, and training materials.
Training & Mentorship
•Host onboarding training programs for new QSU hires and conduct regular training sessions within QSU.
•Establish and mentor a core team of statisticians and data scientists dedicated to the LHS program.
Project Oversight & Strategy
•Guide project assignments related to quality improvement, pragmatic trials, and real-world evidence studies utilizing electronic health records (EHRs).
Collaboration & Relationship Management
•Maintain strong partnerships with clinical advocates of LHS projects across collaborating departments.
•Host onboarding sessions with department leaders to communicate the program’s mission and objectives.
•Establish collaborations with various data teams across campus
Education & Outreach
•Organize educational sessions and lectures for clinical investigators across partnering departments.
•Serve as the primary point of contact for QSU regarding the LHS program.
--------------------------------------------------------------------------------------------------------------------------------
Responsibilities - Senior Biostatistician
Scientific Collaboration & Research Support
•Partner with research investigators on a wide range of scientific studies across the School of Medicine and Stanford Healthcare system.
Study Design & Statistical Planning
•Lead the development of study protocols and statistical analysis plans.
Data Management & Analysis
•Perform data management, visualization, and statistical analysis using advanced methodologies and tools.
Results Interpretation & Reporting
•Interpret statistical results and translate findings into clear, domain-specific language for publications and reports.
Grant & Manuscript Development
•Lead statistical methodology and results sections for grant applications, manuscript submissions, and public health reports.
Methodological Research
•Conduct research on statistical methodologies to enhance study designs and analytical approaches.
Mentorship & Teaching
•Mentor junior statisticians and serve as a KL2 research methodology mentor.
•Deliver lectures, including presentations for Hospital Medicine Grand Rounds.
